{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:52:23Z","timestamp":1772013143394,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1007\/s11920-006-0040-0","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T12:11:42Z","timestamp":1180786302000},"page":"383-388","source":"Crossref","is-referenced-by-count":25,"title":["Choosing the right medication for the treatment of alcoholism"],"prefix":"10.1007","volume":"8","author":[{"given":"Helen M.","family":"Pettinati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda R.","family":"Rabinowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"40_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/01.ALC.0000057941.57330.39","volume":"27","author":"PL Owen","year":"2003","unstructured":"Owen PL, Slaymaker V, Tonigan JS, et al.: Participation in Alcoholics Anonymous: intended and unintended change mechanisms. Alcohol Clin Exp Res 2003, 27:524\u2013532.","journal-title":"Alcohol Clin Exp Res"},{"key":"40_CR2","volume-title":"Cognitive-Behavioral Coping Skills Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence","author":"R Kadden","year":"1995","unstructured":"Kadden R, Carroll KM, Donovan D, et al.: Cognitive-Behavioral Coping Skills Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. Rockville, MD: US Department of Health and Human Services; 1995. [DHHS publication no. 94-3724.]"},{"key":"40_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1037\/0893-164X.15.2.83","volume":"12","author":"J Morganstern","year":"2001","unstructured":"Morganstern J, Morgan TJ, McCrady BS, et al.: Manualguided cognitive-behavioral therapy training: a promising method for disseminating empirically supported substance abuse treatments to the practice community. Psychol Addict Behav 2001, 12:83\u201388.","journal-title":"Psychol Addict Behav"},{"key":"40_CR4","volume-title":"Motivational Enhancement Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence","author":"WR Miller","year":"1994","unstructured":"Miller WR, Zweben A, DiClemente CC, Rychtarik RG: Motivational Enhancement Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. Rockville, MD: US Department of Health and Human Services; 1994. Project MATCH Monograph Series, Vol 2, No. 94-3723."},{"key":"40_CR5","volume-title":"Motivational Interviewing: Preparing People to Change Addictive Behavior","author":"WR Miller","year":"1991","unstructured":"Miller WR, Rollnick S: Motivational Interviewing: Preparing People to Change Addictive Behavior. New York: Guilford Press; 1991."},{"key":"40_CR6","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1001\/jama.256.11.1449","volume":"256","author":"RK Fuller","year":"1986","unstructured":"Fuller RK, Branchery L, Brightwell DR, et al.: Disulfiram treatment of alcoholism: a Veterans Administration cooperative study. JAMA 1986, 256:1449\u20131455.","journal-title":"JAMA"},{"key":"40_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/01.jcp.0000222512.25649.08","volume":"23","author":"JJ Suh","year":"2006","unstructured":"Suh JJ, Pettinati HM, Kampman KM, O\u2019Brien CP: The status of disulfiram: a half of a century later. J Clin Psychopharmacol 2006, 23:290\u2013302. A comprehensive review of the clinical trial literature on disulfiram for the treatment of alcohol dependence, cocaine dependence, and co-occurring alcohol and cocaine dependence.","journal-title":"J Clin Psychopharmacol"},{"key":"40_CR8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1521-0391.2003.tb00543.x","volume":"12","author":"TL Mark","year":"2003","unstructured":"Mark TL, Kranzler HR, Poole VH, et al.: Barriers to the use of medications to treat alcoholism. Am J Addict 2003, 12:281\u2013294.","journal-title":"Am J Addict"},{"key":"40_CR9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/10550490390226914","volume":"12","author":"HM Pettinati","year":"2003","unstructured":"Pettinati HM, Monterosso J, Lipkin C, Volpicelli JR: Patient attitudes toward treatment predict attendance in clinical pharmacotherapy trials of alcohol and drug treatment. Am J Addict 2003, 12:324\u2013335.","journal-title":"Am J Addict"},{"key":"40_CR10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.1997.01830200071010","volume":"54","author":"JR Volpicelli","year":"1997","unstructured":"Volpicelli JR, Rhines KC, Rhines JS, et al.: Naltrexone and alcohol dependence: role of subject compliance. Arch Gen Psychiatry 1997, 54:737\u2013742.","journal-title":"Arch Gen Psychiatry"},{"key":"40_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0014-2999(96)00174-4","volume":"305","author":"R Spanagel","year":"1996","unstructured":"Spanagel R, Holter SM, Allingham K, et al.: Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 1996, 305:39\u201344.","journal-title":"Eur J Pharmacol"},{"key":"40_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0014-2999(96)00175-6","volume":"305","author":"R Spanagel","year":"1996","unstructured":"Spanagel R, Putzke J, Stefferl A, et al.: Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat. Eur J Pharmacol 1996, 305:45\u201350.","journal-title":"Eur J Pharmacol"},{"key":"40_CR13","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","volume":"293","author":"JC Garbutt","year":"2005","unstructured":"Garbutt JC, Kranzler HR, O\u2019Malley SS, et al.: Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA 2005, 293:1617\u20131625. The main outcome paper for a large, multisite clinical trial (N = 627) of injectable naltrexone for the treatment of alcohol dependence.","journal-title":"JAMA"},{"key":"40_CR14","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","volume":"295","author":"RF Anton","year":"2006","unstructured":"Anton RF, O\u2019Malley SS, Ciraulo DA, et al.: Combined pharmacotherapies and behavioral interventions for alcohol dependence. The COMBINE study: a randomized controlled trial. JAMA 2006, 295:2003\u20132017. The main outcome paper for a large, multisite clinical trial (N = 1383) of naltrexone and acamprosate, both alone and in combination, delivered in the context of two psychosocial treatments.","journal-title":"JAMA"},{"key":"40_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1300\/J069v19n01_06","volume":"19","author":"HM Pettinati","year":"2000","unstructured":"Pettinati HM, Volpicelli JR, Pierce JD, Jr, O\u2019Brien CP: Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J Addict Dis 2000, 19:71\u201383.","journal-title":"J Addict Dis"},{"key":"40_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0741-8329(95)02038-1","volume":"13","author":"CP O\u2019Brien","year":"1996","unstructured":"O\u2019Brien CP, Volpicelli LA, Volpicelli JR: Naltrexone in the treatment of alcoholism: a clinical review. Alcohol 1996, 13:35\u201339.","journal-title":"Alcohol"},{"key":"40_CR17","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","volume":"28","author":"DW Oslin","year":"2003","unstructured":"Oslin DW, Berrettini W, Kranzler HR, et al.: A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 2003, 28:1546\u20131552. An analysis of genotype as a predictor of naltrexone response. The authors conclude that a polymorphism of the \u00ec-opioid receptor gene is associated with good clinical response to naltrexone in an alcohol-dependent population.","journal-title":"Neuropsychopharmacology"},{"key":"40_CR18","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/0024-3205(89)90167-7","volume":"45","author":"C Gianoulakis","year":"1989","unstructured":"Gianoulakis C, B\u00e9liveau D, Angelogianni P, et al.: Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci 1989, 45:1097\u20131109.","journal-title":"Life Sci"},{"key":"40_CR19","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1037\/0022-006X.64.5.1044","volume":"64","author":"AJ Jaffe","year":"1996","unstructured":"Jaffe AJ, Rounsaville B, Chang G, et al.: Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching. J Consult Clin Psychol 1996, 64:1044\u20131053.","journal-title":"J Consult Clin Psychol"},{"key":"40_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S0893-133X(01)00416-X","volume":"26","author":"AC King","year":"2002","unstructured":"King AC, Schluger J, Gunduz M, et al.: Hypothalamicpituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism. Neuropsychopharmacology 2002, 26:778\u2013788.","journal-title":"Neuropsychopharmacology"},{"key":"40_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/105504901750532148","volume":"10","author":"JR Monterosso","year":"2001","unstructured":"Monterosso JR, Flannery BA, Pettinati HM, et al.: Predicting treatment response to naltrexone: the influence of craving and family history. Am J Addict 2001, 10:258\u2013268.","journal-title":"Am J Addict"},{"key":"40_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/01.ALC.0000108656.81563.05","volume":"28","author":"K Mann","year":"2004","unstructured":"Mann K, Lehert P, Morgan MY: The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res 2004, 28:51\u201363. A meta-analysis of the clinical trial literature on acamprosate for the treatment of alcohol dependence.","journal-title":"Alcohol Clin Exp Res"},{"key":"40_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jpsychires.2006.02.002","volume":"40","author":"BJ Mason","year":"2006","unstructured":"Mason BJ, Goodman AG, Chabac S, Lehert P: Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. J Psychiatr Res 2006, 40:383\u2013393.","journal-title":"J Psychiatr Res"},{"key":"40_CR24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0447.1992.tb03316.x","volume":"369","author":"C Brewer","year":"1992","unstructured":"Brewer C: Controlled trials of antabuse in alcoholism: the importance of supervision and adequate dosage. Acta Psychiatr Scand Suppl 1992, 369:51\u201358.","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"40_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1360-0443.2004.00597.x","volume":"99","author":"RK Fuller","year":"2004","unstructured":"Fuller RK, Gordis E: Does disulfiram have a role in alcoholism treatment today? Addiction 2004, 99:21\u201324.","journal-title":"Addiction"},{"key":"40_CR26","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","volume":"361","author":"BA Johnson","year":"2003","unstructured":"Johnson BA, Ait-Daoud N, Bowden CL, et al.: Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 2003, 361:1677\u20131685.","journal-title":"Lancet"},{"key":"40_CR27","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/archpsyc.61.9.905","volume":"61","author":"BA Johnson","year":"2004","unstructured":"Johnson BA, Ait-Daoud N, Akhtar FZ, Ma JZ: Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals. Arch Gen Psychiatry 2004, 61:905\u2013912.","journal-title":"Arch Gen Psychiatry"},{"key":"40_CR28","unstructured":"Pettinati HM, Kampman KM, Macfadden W, et al.: A randomized placebo-controlled pilot trial of quetiapine for the treatment of alcohol dependence. Paper presented at the 46th Annual New Clinical Drug Evaluation Unit Meeting. Boca Raton, FL; June 12\u201315, 2006."},{"key":"40_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","volume":"60","author":"F Kiefer","year":"2003","unstructured":"Kiefer F, Jahn H, Tarnaske T, et al.: Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism. Arch Gen Psychiatry 2003, 60:92\u201399.","journal-title":"Arch Gen Psychiatry"},{"key":"40_CR30","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1176\/ajp.156.11.1758","volume":"156","author":"RF Anton","year":"1999","unstructured":"Anton RF, Moak DH, Waid LR, et al.: Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 1999, 156:1758\u20131764.","journal-title":"Am J Psychiatry"},{"key":"40_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1300\/J069v19n01_06","volume":"19","author":"HM Pettinati","year":"2000","unstructured":"Pettinati HM, Volpicelli JR, Pierce JD, Jr, O\u2019Brien CP: Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J Addict Dis 2000, 19:71\u201383.","journal-title":"J Addict Dis"},{"key":"40_CR32","volume-title":"Medical Management Treatment Manual: A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence","author":"HM Pettinati","year":"2004","unstructured":"Pettinati HM, Weiss RD, Miller WR, et al.: Medical Management Treatment Manual: A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. Bethesda, MD: US Department of Health and Human Services; 2004. NIAAA COMBINE Monograph Series, Vol 2. [DHHS publication no. 04-5289.]"},{"key":"40_CR33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.15288\/jsas.2005.s15.170","volume":"15","author":"HM Pettinati","year":"2005","unstructured":"Pettinati HM, Weiss RD, Dundon W, et al.: A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence. J Stud Alcohol Suppl 2005, 15:170\u2013178.","journal-title":"J Stud Alcohol Suppl"},{"key":"40_CR34","volume-title":"Combining Medication and Psychosocial Treatments for Addictions: The BRENDA Approach","author":"JR Volpicelli","year":"2001","unstructured":"Volpicelli JR, Pettinati HM, McLellan AT, O\u2019Brien CP: Combining Medication and Psychosocial Treatments for Addictions: The BRENDA Approach. New York: Guilford Press; 2001."},{"key":"40_CR35","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/j.1360-0443.2004.00884.x","volume":"99","author":"RD Weiss","year":"2004","unstructured":"Weiss RD: Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction 2004, 99:1382\u20131392.","journal-title":"Addiction"},{"key":"40_CR36","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/j.1530-0277.2001.tb02356.x","volume":"25","author":"HR Kranzler","year":"1998","unstructured":"Kranzler HR, Modesto-Lowe V, Nuwayser ES: Sustainedrelease naltrexone for alcoholism treatment: a preliminary study. Alcohol Clin Exp Res 1998, 25:1335\u20131341.","journal-title":"Alcohol Clin Exp Res"},{"key":"40_CR37","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/01.ALC.0000130804.08397.29","volume":"28","author":"HR Kranzler","year":"2004","unstructured":"Kranzler HR, Wesson DR, Billot L: Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial. Alcohol Clin Exp Res 2004, 28:1051\u20131059.","journal-title":"Alcohol Clin Exp Res"},{"key":"40_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s002130050156","volume":"129","author":"AC King","year":"1997","unstructured":"King AC, Volpicelli JR, Frazer A, O\u2019Brien CP: Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology 1997, 129:15\u201322.","journal-title":"Psychopharmacology"},{"key":"40_CR39","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.biopsych.2004.07.016","volume":"56","author":"HM Pettinati","year":"2004","unstructured":"Pettinati HM: Antidepressant treatment of co-occurring depression and alcohol dependence. Biol Psychiatry 2004, 56:785\u2013792. A comprehensive review of the clinical trial literature on antidepressant pharmacotherapy for the treatment of co-occurring depression and alcohol dependence.","journal-title":"Biol Psychiatry"},{"key":"40_CR40","volume-title":"Updating Estimates of the Economic Costs of Alcohol Abuse in the United States: Estimates, Update Methods and Data","author":"H Harwood","year":"1998","unstructured":"Harwood H: Updating Estimates of the Economic Costs of Alcohol Abuse in the United States: Estimates, Update Methods and Data. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 1998."},{"key":"40_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.drugalcdep.2004.02.004","volume":"74","author":"BF Grant","year":"2004","unstructured":"Grant BF, Dawson DA, Stinson FS: The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991\u20131992 and 2001\u20132002. Drug Alcohol Depend 2004, 74:223\u2013234.","journal-title":"Drug Alcohol Depend"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-006-0040-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11920-006-0040-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-006-0040-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-006-0040-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:23:07Z","timestamp":1683865387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11920-006-0040-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1007\/s11920-006-0040-0","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}